相关实验视频
Updated: Jan 13, 2026

05:05
Establishing a Device for Sleep Deprivation in Mice
Published on: September 22, 2023
2.3K
基于固体分散的功能乳制品饮料的开发和优化及其在小鼠中的促进睡眠的影响
Beizhi Zhang1,2, Fuzhi Xie1,2, Nannan Chen2,3
1National Center of Technology Innovation for Comprehensive Utilization of Saline-Alkali Land, Dongying 257000, China.
Foods (Basel, Switzerland)
|January 10, 2026
概括
这项研究在功能性乳制品饮料中开发了脊柱素固体分散,以改善睡眠. 这种新型配方增强了辛素的生物可用性,并且在体内表现出显著的促进睡眠的效果.
科学领域:
- 药理学 药理学是指药理学的学科.
- 食品科学 食品科学 食品科学
- 材料科学 材料科学 材料科学
背景情况:
- 失眠是一个全球性的健康问题,常规治疗导致不良影响.
- 来自 Ziziphi Spinosae 精液的脊柱蛋白显示出睡眠的好处,但由于溶解性和生物利用性不佳而受到影响.
- 开发有效的传递系统,用于天然化合物,如氨酸对于治疗应用至关重要.
研究的目的:
- 通过使用固体分散技术,增强脊素的可溶性和口服生物可用性.
- 为改善睡眠而配制一种功能性的乳制品饮料,其中包含了固体分散的脊柱蛋白.
- 评估开发的功能饮料的促进睡眠的疗效和药理动力学特征.
主要方法:
- 使用溶剂融方法制备的固体散布,通过L9(34) 直角设计进行优化.
- 在体外溶解,在人类结肠腺癌细胞中的细胞吸收研究,以及粉末X射线衍射 (PXRD) 分析.
- 使用二次直角实验优化功能乳制品饮料配方,并评估小鼠体内促进睡眠的影响.
主要成果:
- 固体分散呈现出较高的溶解速率与纯粹的氨酸相比,较小的颗粒显示出更快的溶解.
- 细胞吸收研究证实,较小颗粒的辛素固体分散物的细胞内化得到了改善.
- 基于固体分散的功能性乳制品饮料表现出显著的促进睡眠的效果,改善记忆障碍,并在体内增强了氨酸的生物利用性.
结论:
- 固体分散技术有效地克服了氨酸的可溶性和生物利用性限制.
- 开发的功能乳制品饮料代表了一种有希望的,自然的方法来管理失眠.
- 这项研究强调了将天然化合物与功能性食品的先进交付系统相结合的潜力.
相关概念视频
Substance Use Disorders Affecting Sleep
394
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
394
Sedatives and Hypnotics Drugs: Miscellaneous Agents
497
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
497
Management of Insomnia
518
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
518

